Retatrutides Phase 3 data is strong and accumulating, but it does not have the same depth of real-world experience that Tirzepatide has built since its 2022 approval
Redox status is altered in G6PD deficient RBCs, supporting the idea that G6PD deficiency confers protection against malarial infection (although predisposes to hemolysis)
Upon activation by GLP-1RAs, GLP-1R initiates diverse intracellular cascades, such as the cyclic adenosine monophosphate (cAMP) / protein kinase A (PKA) pathway and phosphatidylinositol 3-kinase (PI3K) / protein kinase B (Akt) signaling pathway [1, 9]
The haemolytic effect of primaquine
You could end up with areas of higher or lower concentration, which compromises its efficacy as a consistent bacteriostatic agent
That is more than twice the uptake of any prior weight-loss drug launch in US history